Latest news with #AnuAcharya
Time of India
3 days ago
- Business
- Time of India
Mapmygenome acquires Canadian CRO Microbiome Insights
HYDERABAD: AI-driven genomics and personalised health player Mapmygenome has acquired Canadian microbial sequencing player Microbiome Insights. The acquisition includes the CAP-accredited (College of American Pathologists) Canadian laboratory of Microbiome Insights as well as its intellectual property. Though the Hyderabad-based Mapmygenome did not divulge the size of acquisition, its founder & CEO Anu Acharya confirmed that it had acquired 100% stake in the 10-year-old Canadian company. She said the acquisition would boost Mapmygenome's scientific prowess and enable its global expansion. Microbiome Insights, which has supported over 600 global clients with more than 1,000 cutting-edge microbiome studies, is a leading partner for academic, clinical, and industry researchers. It was founded by renowned global experts such as Dr Brett Finlay, Dr William Mohn, and Malcolm Kendall. While post-acquisition Microbiome Insights will maintain its role as a premier CRO (clinical research organisation), Mapmygenome said it will roll out its integrated genomics and microbiome testing services to North America to make holistic, data-driven health solutions more accessible. 'The human microbiome is pivotal to health, and this acquisition positions us as a leader in this area. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Esta nueva alarma con cámara es casi regalada en Sarandí (ver precio) Verisure Undo We gain exceptional expertise in metagenomics, transcriptomics, and targeted metabolomics to serve academic, biotech, and clinical sectors,' said Acharya. She said the buy will accelerate the company's North American footprint, aligning with Mapmygenome's strategic vision of growth through targeted acquisitions as it works towards its listing on the Indian bourses later this year. Microbiome Insights CEO Malcolm Kendall said the deal would provide the company the resources and capabilities to offer higher quality services to clients and accelerate growth. Microbiome Insights offers end-to-end microbiome sequencing and comprehensive bioinformatic analysis for sectors such as pharma, biotech, nutrition, cosmetics, agriculture as well as government institutions and has enabled over 1,000 studies. These range from basic research to clinical trials, and biomarker discovery to machine-learning based modelling. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
The Hindu
3 days ago
- Business
- The Hindu
MapMyGenome acquires Canada-based Microbiome Insights
Hyderabad-based genomics and microbiome testing firm MapMyGenome has acquired Canadian company Microbiome Insights, a globally recognised leader in microbial sequencing, in a move aimed at expanding its global presence and deepening scientific capabilities. The acquisition includes Microbiome Insights' CAP-accredited laboratory in Canada, along with its intellectual property portfolio. This development will strengthen MapMyGenome's research and clinical offerings, particularly in the fields of metagenomics, transcriptomics, and targeted metabolomics. It also marks the company's formal entry into the North American market with plans to roll out integrated genomics and microbiome testing services across the region, said a release. MapMyGenome CEO and founder Anu Acharya described the acquisition as a major milestone in the company's global strategy. 'The human microbiome is pivotal to health, and this acquisition positions us as a leader in this area. It accelerates our North American footprint, aligning with our strategic vision of growth through targeted acquisitions leading up to our listing on the Indian market later this year,' she said. Malcolm Kendall, CEO of Microbiome Insights, called the merger an opportunity to enhance service quality and broaden global reach. 'Joining forces with MapMyGenome provides the resources and capabilities to offer higher quality services to our clients and accelerate growth. The combination of their expertise in AI-driven genomics solutions and our deep microbiome expertise will result in a new standard of cutting-edge services for clients worldwide,' he said.
